Publicaciones
-
Cuenca-Barrales C, Baselga E, Del Boz-González J, Vicente-Villa MA, Palencia-Pérez SI, Campos-Domínguez M, Valdivieso-Ramos M, Martín-Santiago A, Montserrat-García MT, Azón-Masoliver A, Feito-Rodríguez M, Domínguez-Cruz JJ, Roé-Crespo E, Salas-Márquez C, Giacaman A, Lorente-Lavirgen AI, Quintana-Castanedo L, de Vega-Martínez M, García-Doval I and Bernabéu-Wittel J.
Baseline Description of the Spanish Academy of Dermatology Infantile Haemangioma Nationwide Prospective Cohort. Comparison of Patients Treated with Propranolol in Routine Clinical Practice with Previous Pivotal Clinical Trial Data
Actas Dermo-Sifiliograficas . 112(9): 806-816. Nº de citas: 4
-
Holm A, Te Loo M, Schultze Kool L, Salminen P, Celis V, Baselga E, Duignan S, Dvorakova V, Irvine AD, Boon LM, Vikkula M, Ghaffarpour N, Niemeyer CM, Rössler J and Kapp FG.
Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference Network
Frontiers in pediatrics . 9: 697960-697960. Nº de citas: 15
-
Rusiñol L, Amat-Samaranch V, Baselga E, Puig L and Roé E.
Prepubertal retroareolar cysts
PEDIATRIC DERMATOLOGY . 38(5): 1368-1369. Nº de citas: 2
-
Puttgen, KB, Hansen, LM, Lauren, C, Stefanko, N, Mathes, E, Olsen, GM, Tollefson, MM, Adams, D, Baselga E, Chamlin, S, Corey, K, Frascari, FF, Frieden, IJ, Galligan, ER, Gupta, D, Haggstrom, A, Horii, K, Hornik, CP, Klajn, J, Liberman, L, Mancini, A, Mannschreck, D, McGinness, A, McCuaig, C, Newell, B, Nguyen, H, Nopper, A, Oyesanya, T, Powell, J, Reynolds, M, Rios, M, Siegel, DH, Ward, K, Garzon, MC, Frommelt, P and Drolet, BA.
Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY . 85(2): 345-352. Nº de citas: 20
-
Rössler J, Baselga E, Davila V, Celis-Passini V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM and Kapp FG.
Severe adverse events during sirolimus "off-label" therapy for vascular anomalies
PEDIATRIC BLOOD & CANCER . 68(8): . Nº de citas: 46
-
López-Sánchez C, Falla LM, Roé-Crespo E, Arostegui-Gorospe JI, Mozos A, Bernal S, Iznardo H and Baselga E.
Excellent response to secukinumab in an infant with severe generalized pustular psoriasis
JOURNAL OF DERMATOLOGY . 48(6): 907-910. Nº de citas: 18
-
Muñoz-Garza FZ, Ríos M, Roé-Crespo E, Bernabeu-Wittel J, Montserrat-García MT, Puig L, Gich I and Baselga E.
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage A Randomized Clinical Trial
JAMA DERMATOLOGY . 157(5): 583-587. Nº de citas: 52
-
Dávila Osorio VL, Vicente-Villa MA, Baselga E, Salvador-Hernandez H, Cruz-Martínez O and Prat-Torres CS.
Adverse cutaneous effects of mitogen-activated protein kinase inhibitors in children
PEDIATRIC DERMATOLOGY . 38(2): 420-423. Nº de citas: 8
-
Valdivielso-Ramos, M, Martin-Santiago, A, Azana, JM, Hernandez-Nunez, A, Vera, A, Perez, B, Tercedor, J, Feito, M, Vicente-Villa MA, Prat-Torres CS, Lopez-Gutierrez, JC, Garnacho, G, Baselga E, Roe, E, Palencia, S, Cordero, P, Moreno, R, Agudo, A, de la Cueva, P and Torrelo, A.
Capillary malformation-arteriovenous malformation syndrome: a multicentre study
CLINICAL AND EXPERIMENTAL DERMATOLOGY . 46(2): 300-305. Nº de citas: 34
-
Iznardo H, Baselga E, Mozos A, Szafranska J, Orellana-Fernández R and Roé E.
Net-like superficial lymphatic malformation
PEDIATRIC DERMATOLOGY . 38(2): 516-517. Nº de citas: 5
